Risk of osteonecrosis in patients with systemic lupus erythematosus: A nationwide population-based study

Eur J Intern Med. 2016 Nov:35:e23-e24. doi: 10.1016/j.ejim.2016.07.004. Epub 2016 Jul 15.

Authors

A Dima¹, A B Pedersen², L Pedersen², C Baicus³, R W Thomsen²

Affiliations

¹ Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy and RECIF, Bucharest, Romania. Electronic address: alina_dima@outlook.com.
² Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
³ Department of Internal Medicine, Carol Davila University of Medicine and Pharmacy and RECIF, Bucharest, Romania.

PMID: 27425656
DOI: 10.1016/j.ejim.2016.07.004

No abstract available

Keywords: Corticosteroids; Incidence; Osteonecrosis; Systemic lupus erythematosus.

Publication types

Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Aged
Denmark / epidemiology
Female
Humans
Incidence
Logistic Models
Lupus Erythematosus, Systemic / complications*
Male
Middle Aged
Osteonecrosis / drug therapy
Osteonecrosis / epidemiology*
Risk Factors

Substances

Adrenal Cortex Hormones